申请人:Marion Laboratories, Inc.
公开号:US03962254A1
公开(公告)日:1976-06-08
N-substituted cyclopentano[h]-1,2,3,4-tetrahydroisoquinolines of the formula ##SPC1## Wherein R and R.sub.1 represent hydroxy, lower alkoxy, lower akanoyloxy or aryl-lower alkanoyloxy groups, R.sub.3 represents hydrogen or a lower alkyl group and R.sub.4 represents a lower alkyl, arylcarbonyl, aryl-lower alkyl, benzhydryl-lower alkyl, lower alkanoyl, aryl-lower alkanoyl, benzhydryl-lower akanoyl or benzhydrylcarbonyl group, and acid addition salts and quaternary ammonium salts thereof, and pharmaceutical compositions containing the compounds useful for lowering blood pressure in animals.
化合物的公式为##SPC1## 其中R和R.sub.1代表羟基,较低的烷氧基,较低的酰氧基或芳基-较低的酰氧基基团,R.sub.3代表氢或较低的烷基基团,R.sub.4代表较低的烷基,芳基羰基,芳基-较低的烷基,苯甲基-较低的烷基,较低的酰基,芳基-较低的酰基,苯甲基-较低的酰基或苯甲基羰基基团,以及酸加成盐和季铵盐,以及含有这些化合物的制药组合物,用于降低动物的血压。